Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors

Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors

US Patent 12018016 · Granted Jun 25, 2024

Estimated economic value: $934,963,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases2025
Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases2025
Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases2025
Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases2025
Azetidinyl-acetamides as CXCR7 inhibitors2025
Azetidinyl-acetamides as CXCR7 inhibitors2025
Azetidinyl-acetamides as CXCR7 inhibitors2025
Azetidinyl-acetamides as CXCR7 inhibitors2025
Methods for treatment of diseases involving acidic or hypoxic diseased tissues2025
Peptide conjugates of cytotoxins as therapeutics2025
Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases2025
Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases2025